Approach to critical illness myopathy and polyneuropathy in the older SARS-CoV-2 patients

J Clin Neurosci. 2020 Sep:79:241-245. doi: 10.1016/j.jocn.2020.07.058. Epub 2020 Jul 24.

Abstract

One of the major concerns of the health care community and the public surrounding the SARS-CoV-2 pandemic is the availability and use of ventilators. Unprecedented surges of patients presented to intensive care units across the country, with older adults making up a large proportion of the patient population. This paper illustrates contemporary approaches to critical illness myopathy (CIM), critical illness polyneuropathy (CIP), and critical illness polyneuromyopathy (CIPNM) in older patients, including incidence, risk factors, mechanisms for pathology, diagnosis, contemporary treatment approaches, and outcomes. We hope that the following analysis may help educate clinicians and ultimately decrease the duration of the mechanical ventilation required by these patients, resulting in improved clinical outcomes and an increase in ventilator availability for other patients in need.

Keywords: COVID-19; Critical illness myopathy; Critical illness polyneuropathy; Intensive care unit-acquired weakness; Older adults; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • Animals
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / therapy
  • Critical Illness
  • Humans
  • Muscular Diseases / etiology*
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / therapy
  • Polyneuropathies / etiology*
  • Respiration, Artificial
  • Risk Factors
  • SARS-CoV-2